2-tert-butylhydroquinone has been researched along with bardoxolone methyl in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, E; Han, L; Hu, X; Ko, CC; Kwon, J; Lee, DJ; Nay, N; Powers, J; Tseng, H; Wong, SW; Wu, TH; Xue, P | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and bardoxolone methyl
Article | Year |
---|---|
CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.
Topics: Animals; Antioxidants; Cell Differentiation; Cell Line; Cells, Cultured; Hydroquinones; Isothiocyanates; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oleanolic Acid; Osteoclasts; Osteogenesis; RANK Ligand; Reactive Oxygen Species; Sulfoxides | 2019 |